U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
179071179071A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in Patients With New Onset Epilepsy Requiring Rapid Initiation of Antiepileptic Drug TreatmentCompletedNo Results AvailableEpilepsyDrug: topiramate, phenytoinhttps://ClinicalTrials.gov/show/NCT00210782
179072179072A Study of the Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: paliperidone ER Oroshttps://ClinicalTrials.gov/show/NCT00210769
179073179073Pharmacokinetic/ Pharmacodynamic Study of Epoetin Alfa (PROCRIT) in Critically Ill Patients.CompletedNo Results AvailableAnemia|Critical IllnessDrug: epoetin alfahttps://ClinicalTrials.gov/show/NCT00210756
179074179074Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT) in the Treatment of Anemia.CompletedNo Results AvailableAnemia|Kidney DiseasesDrug: epoetin alfahttps://ClinicalTrials.gov/show/NCT00210743
179075179075The Duration StudyTerminatedNo Results AvailableAnemiaDrug: epoetin alfahttps://ClinicalTrials.gov/show/NCT00210730
179076179076A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: paliperidone palmitatehttps://ClinicalTrials.gov/show/NCT00210717
179077179077A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature EjaculationCompletedNo Results AvailableErectile DysfunctionDrug: Dapoxetinehttps://ClinicalTrials.gov/show/NCT00210704
179078179078A Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective DisorderCompletedNo Results AvailableSchizophreniaDrug: Risperidonehttps://ClinicalTrials.gov/show/NCT00210691
179079179079A Study to Evaluate Intravaginal Ejaculation Time in Men With and Without Premature EjaculationCompletedNo Results AvailableErectile DysfunctionBehavioral: No interventionhttps://ClinicalTrials.gov/show/NCT00210678
179080179080A Study to Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care TreatmentAvailableNo Results AvailableSarcomaDrug: Trabectedinhttps://ClinicalTrials.gov/show/NCT00210665
179081179081An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With EpilepsyCompletedNo Results AvailableEpilepsy|Epilepsies, PartialDrug: RWJ 333369:https://ClinicalTrials.gov/show/NCT00210652
179082179082A Study of Incidence of Musculoskeletal Disorders in Children Who Have Received Levofloxacin or a Standard Non-Fluoroquinolone Therapy for Acute Bacterial InfectionCompletedHas ResultsMusculoskeletal DiseasesDrug: No interventionhttps://ClinicalTrials.gov/show/NCT00210639
179083179083Assess Functional Outcomes in Anemic, Critically Ill, Trauma Patients When Taking Epoetin AlfaTerminatedHas ResultsAnemiaDrug: PROCRIT|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00210626
179084179084A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature EjaculationCompletedNo Results AvailableSexual Dysfunction|EjaculationDrug: Dapoxetinehttps://ClinicalTrials.gov/show/NCT00210613
179085179085Early and Standard Intervention With 120,000 Units of PROCRIT (Epoetin Alfa) Every Three Weeks in Patients Receiving ChemotherapyCompletedNo Results AvailableAnemiaDrug: PROCRIT (Epoetin alfa)https://ClinicalTrials.gov/show/NCT00210600
179086179086An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or RadiationCompletedNo Results AvailableAnemia|NeoplasmsDrug: epoetin alfahttps://ClinicalTrials.gov/show/NCT00210587
179087179087A Pilot Study of Topiramate in Childhood Absence EpilepsyCompletedNo Results AvailableEpilepsy, AbsenceDrug: topiramatehttps://ClinicalTrials.gov/show/NCT00210574
179088179088A Study of the Effectiveness and Safety of Tramadol HCl/Acetaminophen Compared to Placebo in Treating Acute Low Back PainTerminatedNo Results AvailableBack Pain|Low Back PainDrug: tramadol hydrochloride , acetaminophenhttps://ClinicalTrials.gov/show/NCT00210561
179089179089A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: paliperidone palmitatehttps://ClinicalTrials.gov/show/NCT00210548
179090179090A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Attacks in ChildrenCompletedNo Results AvailableMigraine|Vascular HeadachesDrug: Topiramate; Placebohttps://ClinicalTrials.gov/show/NCT00210535
179091179091An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With EpilepsyCompletedNo Results AvailableEpilepsy|Epilepsies, PartialDrug: RWJ 333369https://ClinicalTrials.gov/show/NCT00210522
179092179092A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine HeadacheCompletedNo Results AvailableMigraineDrug: almotriptan malatehttps://ClinicalTrials.gov/show/NCT00210509
179093179093Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of MigraineCompletedNo Results AvailableMigraine|Classic Migraine|Common MigraineDrug: topiramate; almotriptan malatehttps://ClinicalTrials.gov/show/NCT00210496
179094179094A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in AdolescentsCompletedNo Results AvailableMigraineDrug: almotriptan malatehttps://ClinicalTrials.gov/show/NCT00210483
179095179095A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck CancerCompletedHas ResultsSquamous Cell Carcinoma of the Head and NeckBiological: IRX-2|Drug: Cyclophosphamide|Drug: Indomethacin|Drug: Zinc|Drug: Omeprazolehttps://ClinicalTrials.gov/show/NCT00210470
179096179096Efficacy and Safety of Lanreotide Autogel (60, 90 or 120 mg) in Acromegalic PatientsCompletedNo Results AvailableAcromegalyDrug: Lanreotide (Autogel formulation)https://ClinicalTrials.gov/show/NCT00210457
179097179097Efficacy Study of Dysport® in the Treatment of Anal Fissure.CompletedNo Results AvailableAnal FissureDrug: Botulinum toxin type A (Dysport)https://ClinicalTrials.gov/show/NCT00210444
179098179098Post Marketing Surveillance Study of DysportCompletedNo Results AvailableBlepharospasm|Hemifacial Spasm|Cervical Dystonia|Spasmodic Torticollis|Cerebral Palsy|Muscle Spasticity|Cerebrovascular Accident|Equinus Deformity|Facial Hyperdynamic Lineshttps://ClinicalTrials.gov/show/NCT00210431
179099179099Effectiveness of Targeting Food Aid to Malnourished Children Compared to Targeting All Children Under Two YearsCompletedNo Results AvailableMalnutritionDietary Supplement: Fortified food rations|Behavioral: Education and communication to improve feeding practiceshttps://ClinicalTrials.gov/show/NCT00210418
179100179100Feasibility and Effectiveness of Distributing Micronutrient Sprinkles to Reduce Prevalence of AnemiaCompletedNo Results AvailableAnemiaDietary Supplement: "Sprinkles" containing mulitple micronutrients|Behavioral: Education/communication on use of micronutrient sprinkles|Dietary Supplement: Fortified food aid (corn-soy blend)https://ClinicalTrials.gov/show/NCT00210405

* Görseller ve İçerik tekif hakkına sahip olabilir